Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The U.S. Food and Drug Administration has its hands full making sure medical AI products are safe, efficacious and trustworthy before they hit the market. The rise of ever-more-innovative iterations of the technology—not least generative AI—is only adding to the burden.
Among AI’s most watchful stakeholders are healthcare organizations in need of AI talent and AI talent in need of work in healthcare. Both groups need to keep up with the technology in its present as well as future iterations.
Dynocardia has now received nearly $5.1 million in funding from the NHLBI to help speed commercializing its wrist-worn monitor to avoid the need for invasive catheter BP monitoring.
Timothy Story, MD, said Ascension St. Vincent Medical Center damaged his career and reputation after they fired him without cause. After a three-and-a-half year legal trial, a jury in Indiana agreed.
Healthcare providers might be the most underrated of all AI stakeholders. Never mind that close to half of 200 CEOs surveyed believe healthcare is the field in which AI is likely to make the most transformative contribution.
Chief financial officers are the most likely members of U.S. C-suites to leave their jobs within five years of starting, whether by resignation, retirement, termination or promotion.
Nashville-based HCA Healthcare operates in 21 states, and mass numbers of patients in all but one of them may have had personal information offered for sale as a list on the deep web.
With a bit fewer than 7 million residents, Massachusetts ranks a middling 16th in population among the states. However, when it comes to internet searches for terms associated with emerging technologies per 100,000 residents, the Bay State is No. 1.
It was only last fall that Open AI’s ChatGPT thrust generative AI into the public psyche. Since then, many future-looking surveys have shown unease and trepidation competing hard for mindshare against hope and excitement.
The senior statistician purchased short-term stock options, including some that expired the next day, after allegedly being made aware of Paxlovid’s success in clinical trials ahead of a public announcement.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.